Effects of metronidazole on hepatic CYP3A4 activity

Pharmacotherapy

Volumn 21, Issue 10, 2001, Pages 1192-1195

  Haas, Curtis E ^a   Kaufman, David C ^b   DiCenzo, Robert C ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 3A4; LIVER ENZYME; METRONIDAZOLE;

ADULT; ARTICLE; BREATH ANALYSIS; DRUG METABOLISM; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; INTESTINE PREPARATION; MALE;

ADULT; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BREATH TESTS; CYTOCHROME P-450 ENZYME SYSTEM; DRUG INTERACTIONS; ERYTHROMYCIN; HUMANS; LIVER; MALE; METHYLATION; METRONIDAZOLE; MIXED FUNCTION OXYGENASES; PROSPECTIVE STUDIES;

EID: 0034785771     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.21.15.1192.33896     Document Type: Article

References (31)

1. Cyclosporine interactions with metronidazole and cimetidine
2. Possible interaction between metronidazole and carbamazepine
3. Possible pharmacokinetic interaction with quinidine: Ciprofloxacin or metronidazole?
4. Marked elevation of blood cyclosporin and tacrolimus levels due to concurrent metronidazole therapy
5. The stereoselective interaction of warfarin and metronidazole in man
6. A significant interaction between metronidazole and warfarin
7. Metronidazole impairs clearance of phenytoin but not of alprazolam or lorazepam
8. Interaction between metronidazole and drugs eliminated by oxidative metabolism
9. A study of interaction of low-dose combination oral contraceptive with ampicillin and metronidazole
10. Effects of metronidazole on midazolam metabolism in vitro and in vivo
11. Drug interactions analysis and management
12. Drug interaction facts
13. 14C-erythromycin
14. Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test
15. CYP3A4 and the erythromycin breath test
16. Erythromycin breath test as an assay of glucocorticoid-inducible liver cytochromes P-450. Studies in rats and patients
17. Noninvasive tests of CYP3A enzymes
18. The erythromycin breath test selectively measures P450IIIA in patients with severe liver disease
19. The erythromycin breath test as a predictor of cyclosporine blood levels
20. Erythromycin breath test predicts oral clearance of cyclosporine in kidney transplant recipients
21. Steady-state pharmacokinetics of delavirdine in HIV-positive patients: Effect on erythromycin breath test
22. Predicting drug interactions in vivo from experiments in vitro. Human studies with paclitaxel and ketoconazole
23. Pharmacokinetic interaction between ketoconazole and amprenavir after single doses in healthy men
24. Pharmacokinetic interaction between amprenavir and clarithromycin in healthy male volunteers
25. Effect of metronidazole on theophylline pharmacokinetics
26. Lack of inhibitory effect of metronidazole on theophylline disposition in healthy subjects
27. Drug-cytokine interactions
28. Drug-cytokine interactions. Mechanisms and clinical implications
29. The P-glycoprotein multidrug transporter
30. Molecular basis of cardiovascular drug metabolism: Implications for predicting clinically important drug interactions
31. Interrelationship between substrates and inhibitors of human CYP3A and P-glycoprotein